Parametric Portfolio Associates’s Kezar Life Sciences KZR Stock Holding History

Parametric Portfolio Associates’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.19M	Buy	13,166 +2,913	+28%	+$418K	﹤0.01%	2378
2021 Q4	$1.71M	Buy	10,253 +5,937	+138%	+$670K	﹤0.01%	2527
2021 Q3	$373K	Sell	4,316 -20	-0.5%	-$1.32K	﹤0.01%	3215
2021 Q2	$235K	Buy	4,336 +38	+0.9%	+$2.16K	﹤0.01%	3349
2021 Q1	$256K	Sell	4,298 -33	-0.8%	-$1.93K	﹤0.01%	3781
2020 Q4	$226K	Buy	4,331 +16	+0.4%	+$890	﹤0.01%	3719
2020 Q3	$209K	Buy	4,315 +371	+9%	+$17.7K	﹤0.01%	3642
2020 Q2	$204K	Buy	3,944 +69	+2%	+$3.48K	﹤0.01%	3626
2020 Q1	$169K	Buy	3,875 +278	+8%	+$11.3K	﹤0.01%	3596
2019 Q4	$144K	Buy	3,597 +2,569	+250%	+$79.1K	﹤0.01%	3805
2019 Q3	$34K	Buy	+1,028	New	+$49.6K	﹤0.01%	3913

Other funds holding KZR

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Parametric Portfolio Associates's KZR Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Kezar Life Sciences (KZR) stake by 28% in Q1 2022, buying an estimated $418K and bringing the position to 13,166 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2378.

Parametric Portfolio Associates first reported a position in KZR in Q3 2019 and has held it in 11 quarters since. 123 funds tracked by Wall St. Rank hold KZR as of Q1 2022.

Parametric Portfolio Associates held 13,166 shares of Kezar Life Sciences worth $2.19M as of Q1 2022.
Parametric Portfolio Associates bought 2,913 Kezar Life Sciences shares in Q1 2022, an estimated $418K.
Kezar Life Sciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2378 holding.
Parametric Portfolio Associates first reported a position in Kezar Life Sciences in Q3 2019 and has held it in 11 quarters since.
123 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.